The rapid rise in interest in how bacteria in the gut can be targeted as a key regulator in health and disease has extended beyond the lab and can be reflected by the rapid growth of the pro- and prebiotic and with the more recent emergence of postbiotics, the microbiome focused consumer health facing industry is now estimated to be a multibillion-dollar industry.
Despite the scientific and economical interest, there are still a number of fundamental questions surrounding the functional, clinical and practical applicability of the research that remains unanswered.
Celebrating our fourth year, we will once again combine academic researchers presenting their hottest work, industry case-studies from microbiome-focused nutritional companies as well as the insight of some of the largest CPG companies in the world to provide clarity to these questions.
Time: 09:00 to 18:00
Conference and Focus Day: USD 1698.00